Literature DB >> 26279205

Haploinsufficiency of the NF-κB1 Subunit p50 in Common Variable Immunodeficiency.

Manfred Fliegauf1, Vanessa L Bryant2, Natalie Frede1, Charlotte Slade3, See-Tarn Woon4, Klaus Lehnert5, Sandra Winzer1, Alla Bulashevska1, Thomas Scerri2, Euphemia Leung6, Anthony Jordan7, Baerbel Keller1, Esther de Vries8, Hongzhi Cao9, Fang Yang9, Alejandro A Schäffer10, Klaus Warnatz1, Peter Browett6, Jo Douglass11, Rohan V Ameratunga4, Jos W M van der Meer12, Bodo Grimbacher13.   

Abstract

Common variable immunodeficiency (CVID), characterized by recurrent infections, is the most prevalent symptomatic antibody deficiency. In ∼90% of CVID-affected individuals, no genetic cause of the disease has been identified. In a Dutch-Australian CVID-affected family, we identified a NFKB1 heterozygous splice-donor-site mutation (c.730+4A>G), causing in-frame skipping of exon 8. NFKB1 encodes the transcription-factor precursor p105, which is processed to p50 (canonical NF-κB pathway). The altered protein bearing an internal deletion (p.Asp191_Lys244delinsGlu; p105ΔEx8) is degraded, but is not processed to p50ΔEx8. Altered NF-κB1 proteins were also undetectable in a German CVID-affected family with a heterozygous in-frame exon 9 skipping mutation (c.835+2T>G) and in a CVID-affected family from New Zealand with a heterozygous frameshift mutation (c.465dupA) in exon 7. Given that residual p105 and p50—translated from the non-mutated alleles—were normal, and altered p50 proteins were absent, we conclude that the CVID phenotype in these families is caused by NF-κB1 p50 haploinsufficiency.
Copyright © 2015 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26279205      PMCID: PMC4564940          DOI: 10.1016/j.ajhg.2015.07.008

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  69 in total

Review 1.  Rel/NF-kappaB transcription factors: key mediators of B-cell activation.

Authors:  R Gugasyan; R Grumont; M Grossmann; Y Nakamura; T Pohl; D Nesic; S Gerondakis
Journal:  Immunol Rev       Date:  2000-08       Impact factor: 12.988

Review 2.  Roles of the NF-kappaB pathway in lymphocyte development and function.

Authors:  Steve Gerondakis; Ulrich Siebenlist
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-12-23       Impact factor: 10.005

3.  Progression of selective IgA deficiency to common variable immunodeficiency.

Authors:  Asghar Aghamohammadi; Javad Mohammadi; Nima Parvaneh; Nima Rezaei; Mostafa Moin; Teresa Espanol; Lennart Hammarstrom
Journal:  Int Arch Allergy Immunol       Date:  2008-06-03       Impact factor: 2.749

Review 4.  NF-κB in immunobiology.

Authors:  Matthew S Hayden; Sankar Ghosh
Journal:  Cell Res       Date:  2011-01-18       Impact factor: 25.617

Review 5.  New diagnostic criteria for common variable immune deficiency (CVID), which may assist with decisions to treat with intravenous or subcutaneous immunoglobulin.

Authors:  R Ameratunga; S-T Woon; D Gillis; W Koopmans; R Steele
Journal:  Clin Exp Immunol       Date:  2013-11       Impact factor: 4.330

Review 6.  TACItly changing tunes: farewell to a yin and yang of BAFF receptor and TACI in humoral immunity? New genetic defects in common variable immunodeficiency.

Authors:  Ulrich Salzer; Bodo Grimbacher
Journal:  Curr Opin Allergy Clin Immunol       Date:  2005-12

7.  Autosomal dominant anhidrotic ectodermal dysplasia with immunodeficiency caused by a novel NFKBIA mutation, p.Ser36Tyr, presents with mild ectodermal dysplasia and non-infectious systemic inflammation.

Authors:  Takakazu Yoshioka; Ryuta Nishikomori; Junichi Hara; Keiko Okada; Yoshiko Hashii; Ikuo Okafuji; Seishiro Nodomi; Tomoki Kawai; Kazushi Izawa; Hidenori Ohnishi; Takahiro Yasumi; Tatsutoshi Nakahata; Toshio Heike
Journal:  J Clin Immunol       Date:  2013-07-18       Impact factor: 8.317

8.  Decrease in phenotypic regulatory T cells in subsets of patients with common variable immunodeficiency.

Authors:  J Horn; A Manguiat; L J Berglund; V Knerr; F Tahami; B Grimbacher; D A Fulcher
Journal:  Clin Exp Immunol       Date:  2009-06       Impact factor: 4.330

9.  Immunodeficiency and disseminated mycobacterial infection associated with homozygous nonsense mutation of IKKβ.

Authors:  Siobhan O Burns; Vincent Plagnol; Beatriz Morillo Gutierrez; Daifulah Al Zahrani; James Curtis; Miguel Gaspar; Amel Hassan; Alison M Jones; Marian Malone; Dyanne Rampling; Alex McLatchie; Rainer Doffinger; Kimberly C Gilmour; Frances Henriquez; Adrian J Thrasher; H Bobby Gaspar; Sergey Nejentsev
Journal:  J Allergy Clin Immunol       Date:  2014-03-27       Impact factor: 10.793

Review 10.  Comparison of diagnostic criteria for common variable immunodeficiency disorder.

Authors:  Rohan Ameratunga; Maia Brewerton; Charlotte Slade; Anthony Jordan; David Gillis; Richard Steele; Wikke Koopmans; See-Tarn Woon
Journal:  Front Immunol       Date:  2014-09-15       Impact factor: 7.561

View more
  84 in total

1.  Novel nonsense gain-of-function NFKB2 mutations associated with a combined immunodeficiency phenotype.

Authors:  Hye Sun Kuehn; Julie E Niemela; Karthik Sreedhara; Jennifer L Stoddard; Jennifer Grossman; Christian A Wysocki; M Teresa de la Morena; Mary Garofalo; Jingga Inlora; Michael P Snyder; David B Lewis; Constantine A Stratakis; Thomas A Fleisher; Sergio D Rosenzweig
Journal:  Blood       Date:  2017-08-04       Impact factor: 22.113

Review 2.  30 Years of NF-κB: A Blossoming of Relevance to Human Pathobiology.

Authors:  Qian Zhang; Michael J Lenardo; David Baltimore
Journal:  Cell       Date:  2017-01-12       Impact factor: 41.582

3.  The immunophenotypic fingerprint of patients with primary antibody deficiencies is partially present in their asymptomatic first-degree relatives.

Authors:  Delfien J A Bogaert; Marieke De Bruyne; Veronique Debacker; Pauline Depuydt; Katleen De Preter; Carolien Bonroy; Jan Philippé; Victoria Bordon; Bart N Lambrecht; Tessa Kerre; Andrea Cerutti; Karim Y Vermaelen; Filomeen Haerynck; Melissa Dullaers
Journal:  Haematologica       Date:  2016-09-15       Impact factor: 9.941

4.  RELA haploinsufficiency in CD4 lymphoproliferative disease with autoimmune cytopenias.

Authors:  William A Comrie; Aiman J Faruqi; Susan Price; Yu Zhang; V Koneti Rao; Helen C Su; Michael J Lenardo
Journal:  J Allergy Clin Immunol       Date:  2018-01-02       Impact factor: 10.793

Review 5.  Common variable immune deficiency: Dissection of the variable.

Authors:  Charlotte Cunningham-Rundles
Journal:  Immunol Rev       Date:  2019-01       Impact factor: 12.988

6.  Common variable immunodeficiency-associated endotoxemia promotes early commitment to the T follicular lineage.

Authors:  Carole Le Coz; Bertram Bengsch; Caroline Khanna; Melissa Trofa; Takuya Ohtani; Brian E Nolan; Sarah E Henrickson; Michele P Lambert; Taylor Olmsted Kim; Jenny M Despotovic; Scott Feldman; Olajumoke O Fadugba; Patricia Takach; Melanie Ruffner; Soma Jyonouchi; Jennifer Heimall; Kathleen E Sullivan; E John Wherry; Neil Romberg
Journal:  J Allergy Clin Immunol       Date:  2019-08-22       Impact factor: 10.793

7.  Loss of B Cells in Patients with Heterozygous Mutations in IKAROS.

Authors:  H S Kuehn; B Boisson; M E Conley; S D Rosenzweig; C Cunningham-Rundles; J Reichenbach; A Stray-Pedersen; E W Gelfand; P Maffucci; K R Pierce; J K Abbott; K V Voelkerding; S T South; N H Augustine; J S Bush; W K Dolen; B B Wray; Y Itan; A Cobat; H S Sorte; S Ganesan; S Prader; T B Martins; M G Lawrence; J S Orange; K R Calvo; J E Niemela; J-L Casanova; T A Fleisher; H R Hill; A Kumánovics
Journal:  N Engl J Med       Date:  2016-03-17       Impact factor: 91.245

8.  The Expanding Spectrum of NFkB1 Deficiency.

Authors:  Vanessa L Bryant; Stuart G Tangye
Journal:  J Clin Immunol       Date:  2016-06-23       Impact factor: 8.317

Review 9.  Novel Developments in Primary Immunodeficiencies (PID)-a Rheumatological Perspective.

Authors:  Helen Leavis; Jochen Zwerina; Bernhard Manger; Ruth D E Fritsch-Stork
Journal:  Curr Rheumatol Rep       Date:  2019-09-05       Impact factor: 4.592

10.  Specific antibody deficiency and autoinflammatory disease extend the clinical and immunological spectrum of heterozygous NFKB1 loss-of-function mutations in humans.

Authors:  Cyrill Schipp; Schafiq Nabhani; Kirsten Bienemann; Natalia Simanovsky; Shlomit Kfir-Erenfeld; Nathalie Assayag-Asherie; Prasad T Oommen; Shoshana Revel-Vilk; Andrea Hönscheid; Michael Gombert; Sebastian Ginzel; Daniel Schäfer; Hans-Jürgen Laws; Eitan Yefenof; Bernhard Fleckenstein; Arndt Borkhardt; Polina Stepensky; Ute Fischer
Journal:  Haematologica       Date:  2016-06-30       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.